Ministry of Health, Labour and Welfare - Promoting the reform of the industrial structure of generic pharmaceuticals and aiming to strengthen the supply chain.
Our company will hold a business seminar. 【Seminar Details】 ■ Date and Time: September 18, 2025 (Thursday) 16:30 - 18:30 (Doors open at 16:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Method: In-person, live streaming, archived streaming ■ Instructor: Ministry of Health, Labour and Welfare Medical Affairs Bureau, Medical Industry Promotion and Medical Information Planning Division Director of Pharmaceutical Industry and Venture Support Policy Office Mr. Daisuke Fujii *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
**Lecture Overview** The current supply instability of pharmaceuticals, particularly generic drugs, is rooted in the inefficient manufacturing system of the generic drug industry, characterized by small-batch production of a wide variety of products. This instability has been exacerbated by a decrease in supply from pharmaceutical companies triggered by violations of the Pharmaceutical and Medical Device Act, as well as various factors such as outbreaks of infectious diseases. Therefore, to ensure a stable supply of pharmaceuticals, it is necessary to address both the immediate supply concerns and the medium- to long-term challenges. The Ministry of Health, Labour and Welfare has been working to address the current supply instability by encouraging pharmaceutical companies to increase production and providing subsidies for the establishment of production systems, while also promoting structural reforms in the generic drug industry to tackle medium- to long-term issues. In this presentation, I will explain the current state of stable pharmaceutical supply and the government's initiatives related to it. **Lecture Topics** - Current status of stable pharmaceutical supply and initiatives to ensure stability - Response to immediate supply concerns - Structural reforms in the generic drug industry - Strengthening the pharmaceutical supply chain - Generic drugs and biosimilars - Related Q&A - Business card and information exchange session
Price information
【Course Fee】 1 person: 37,350 yen (including tax) Special offer: One additional person can accompany for free per registered participant (registration required) *For those affiliated with local public organizations, up to 2 people can attend for 11,000 yen (including tax) However, this is limited to in-person attendance or live streaming. Please ensure that the attendance format for both participants is the same.
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
JPI Corporation (Japan Planning Institute) has been providing valuable information for executives and senior management involved in the execution of national policies and national projects, supporting the dissemination of state policies as a 'bridge of knowledge' between 'government', 'administration', and 'citizens' in the form of exclusive real seminars for participants for half a century, aiming to create national knowledge.
![[Seminar] The Current Status of Biopharmaceuticals Including Vaccines in Our Country](https://image.mono.ipros.com/public/product/image/3d2/2001181608/IPROS32315136463393769928.png?w=280&h=280)
![[Seminar] Ministry of Health, Labour and Welfare: Future Prospects of the Generic Pharmaceutical Industry](https://image.mono.ipros.com/public/product/image/8d8/2001188291/IPROS10157133286624865405.png?w=280&h=280)
![[Seminar] Current Situation and Challenges of Supply Shortages of Medical Pharmaceuticals](https://image.mono.ipros.com/public/product/image/9e3/2001523583/IPROS7667559201004464429.png?w=280&h=280)
![[Seminar] Latest Trends in Policies for Stable Supply of Generic Drugs and Corporate Collaboration](https://image.mono.ipros.com/public/product/image/2079072/IPROS10253278751703873794.png?w=280&h=280)
![[Market Report] Global Nausea Relief Chewable Market](https://image.mono.ipros.com/public/product/image/ebb/2001072971/IPROS43998813981636070678.jpeg?w=280&h=280)
